THERAPEUTICS FUNDING PROGRAMS: NEUROIMAGING AND CSF BIOMARKER PROGRAM

ALZHEIMER’S DRUG DISCOVERY FOUNDATION (ADDF)

Objeto

Topic: Alzheimer.

Destination: The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer’s disease and related dementias.

Budget: Up to $6,000,000.

Duration: 1 year (potential for follow-on funding).

Are you interested in this call?

Estás interesado?

Llena el siguiente formulario para recibir más información: